CONTEXT: A teaser article for the DIA 2021 where discussions are expected around decentralised trials and accelerated approval pathways. The DIA has always a great place for the industry to Continue Reading
CONTEXT: Continuing the theme of under-representation in clinical trials that develop new treatments, especially in oncology, this article reports on the discussion at the European Hematology Association (EHA) 2021 Virtual Continue Reading
CONTEXT: Further evidence of ancestry-based disparities in cancer treatment from this study, believed to be the largest of it’s type so far. The analysis of data from over 11,000 men Continue Reading
CONTEXT: Report from ASCO 2021 from the MYLUNG Consortium research study in metastatic NSCLC. The findings based on the results from the first of 5 protocols is a retrospective review Continue Reading
CONTEXT: Surely the next big thing in RWR – “Synthetic Data”. “Yes” you say “and don’t call me Shirley”. Airplane jokes aside, it makes a huge amount of sense to Continue Reading
CONTEXT: Commercial announcement of a joint initiative between Hoffmann-La Roche and BC Cancer along with Canadian Personalised Healthcare Innovation Network (CPHIN) to create an RWE framework in British Columbia to Continue Reading
CONTEXT: As promised, we will keep you up to date on the FDA guidance on RWE in pediatric oncology. It seems the guidance will be available soon, but following a Continue Reading
CONTEXT: Commercial announcement of Picnic Health and Komodo Health partnership to support RWE programs for complex illnesses like MS and haemophilia. IMPACT: Low READ TIME: 1 min Quality Level Mean Continue Reading
CONTEXT: Commercial announcement of CVS Health joining the push for decentralised clinical trials with the formation of a new business unit. This pharmacy chain is just the latest in a Continue Reading
CONTEXT: Commercial announcement of a cloud-based data analytics platform aimed at RWD. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 5 1. “Users can analyze data Continue Reading
